Coinhibitory molecule PD-1 as a therapeutic target in the microenvironment of Multiple Myeloma-Reference-Cited by-同舟云学术

Coinhibitory molecule PD-1 as a therapeutic target in the microenvironment of Multiple Myeloma

Published:2017-09-06 Issue: Volume:17 Page:
ISSN:1568-0096
Container-title:Current Cancer Drug Targets
language:en
Short-container-title:CCDT

Author:

Atanackovic Djordje¹,Luetkens Tim¹,Steinbach Mary¹,Kroger Nicolaus²

Affiliation:

1. Multiple Myeloma Program, Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, United States

2. Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Drug Discovery,Pharmacology,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attempt to assess direct interactions between tumor burden, myeloid-derived suppressor cells and PD-1- and TIM-3-expressing T cells in multiple myeloma patients;Medical Immunology (Russia);2023-06-01

2. Highly proliferative and functional PD-1+ and TIM-3+ T cells are transiently increased in multiple myeloma following autologous hematopoietic stem cell transplantation;International Immunopharmacology;2021-11

3. Targeted therapy of multiple myeloma;Exploration of Targeted Anti-tumor Therapy;2021-10-29

4. Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma;Clinical and Experimental Immunology;2021-05-07

5. Quantitative and functional characteristics of circulating and bone marrow PD-1- and TIM-3-positive T cells in treated multiple myeloma patients;Scientific Reports;2020-11-30